Danazol for heavy menstrual bleeding (Q24243876)

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD001017.PUB2

21 January 2018

12 December 2020

Medical management of dysfunctional uterine bleeding

1 reference

12 December 2020

Measurement of menstrual blood loss in patients complaining of menorrhagia

1 reference

12 December 2020

The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia

1 reference

12 December 2020

Changes in haematological indices, blood viscosity and inhibitors of coagulation during treatment of endometriosis with danazol

1 reference

12 December 2020

Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia

1 reference

12 December 2020

DETERMINATION OF MENSTRUAL BLOOD LOSS

1 reference

12 December 2020

A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia

1 reference

12 December 2020

Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Assessment of medical treatments for menorrhagia.

1 reference

12 December 2020

Hysterectomy and psychiatric disorder: I. Levels of psychiatric morbidity before and after hysterectomy

1 reference

12 December 2020

Dysfunctional uterine bleeding

1 reference

12 December 2020

A preliminary study of factors influencing perception of menstrual blood loss volume

1 reference

12 December 2020

Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization

1 reference

12 December 2020

Comparison between mefenamic acid and danazol in the treatment of established menorrhagia.

1 reference

12 December 2020

The epidemiology of hysterectomy: findings in a large cohort study

1 reference

12 December 2020

Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.

1 reference

12 December 2020

A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia

1 reference

12 December 2020

Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo

1 reference

12 December 2020

A double-blind randomised study comparing danazol and medroxyprogesterone acetate in the management of menorrhagia

1 reference

12 December 2020

Treating Menorrhagia in Primary Care: An Overview of Drug Trials and a Survey of Prescribing Practice

1 reference

12 December 2020

Sources of variation in menstrual blood loss

1 reference

12 December 2020

The effect of danazol on menorrhagia, coagulation mechanisms, haematological indices and body weight

1 reference

12 December 2020

Quality of Life and Patient Satisfaction Following Treatment for Menorrhagia

1 reference

12 December 2020

Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality

1 reference

12 December 2020

Danazol in the Treatment of Menorrhagia: The Effect of a 1 Month Induction Dose (200 mg) and 2 Month's Maintenance Therapy (200 mg, 100 mg, 50 mg or placebo)

1 reference

12 December 2020

Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records.

1 reference

12 December 2020

Efficacy of mefenamic acid in patients with a complaint of menorrhagia

1 reference

12 December 2020